Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.

Drusbosky LM, Singh NK, Hawkins KE, Salan C, Turcotte M, Wise EA, Meacham A, Vijay V, Anderson GG, Kim CC, Radhakrishnan S, Ullal Y, Talawdekar A, Sikora H, Nair P, Khanna-Gupta A, Abbasi T, Vali S, Guha S, Farhadfar N, Murthy HS, Horn BN, Leather HL, Castillo P, Tucker C, Cline C, Pettiford L, Lamba JK, Moreb JS, Brown RA, Norkin M, Hiemenz JW, Hsu JW, Slayton WB, Wingard JR, Cogle CR.

Blood Adv. 2019 Jun 25;3(12):1837-1847. doi: 10.1182/bloodadvances.2018028316.

2.

Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells.

Hawkins KE, Duchen M.

World J Stem Cells. 2019 May 26;11(5):236-253. doi: 10.4252/wjsc.v11.i5.236. Review.

3.

Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A.

Vlahova F, Hawkins KE, Ranzoni AM, Hau KL, Sagar R, Coppi P, David AL, Adjaye J, Guillot PV.

Sci Rep. 2019 May 31;9(1):8126. doi: 10.1038/s41598-019-44572-x.

4.

Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

Yang C, Hawkins KE, Doré S, Candelario-Jalil E.

Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135-C153. doi: 10.1152/ajpcell.00136.2018. Epub 2018 Oct 31.

PMID:
30379577
5.

Using social media to assess care coordination goals and plans for leukemia patients and survivors.

Strekalova YA, Hawkins KE, Drusbosky LM, Cogle CR.

Transl Behav Med. 2018 May 23;8(3):481-491. doi: 10.1093/tbm/ibx075.

PMID:
29800400
6.

NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program.

FitzPatrick LM, Hawkins KE, Delhove JMKM, Fernandez E, Soldati C, Bullen LF, Nohturfft A, Waddington SN, Medina DL, Bolaños JP, McKay TR.

Stem Cell Reports. 2018 Jun 5;10(6):1766-1781. doi: 10.1016/j.stemcr.2018.03.015. Epub 2018 Apr 19.

7.

Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.

Hawkins KE, Corcelli M, Dowding K, Ranzoni AM, Vlahova F, Hau KL, Hunjan A, Peebles D, Gressens P, Hagberg H, de Coppi P, Hristova M, Guillot PV.

Stem Cells Transl Med. 2018 May;7(5):439-449. doi: 10.1002/sctm.17-0260. Epub 2018 Feb 28.

8.

Bioluminescence Monitoring of Promoter Activity In Vitro and In Vivo.

Delhove JMKM, Karda R, Hawkins KE, FitzPatrick LM, Waddington SN, McKay TR.

Methods Mol Biol. 2017;1651:49-64. doi: 10.1007/978-1-4939-7223-4_5.

PMID:
28801899
9.

Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery.

Hawkins KE, DeMars KM, Alexander JC, de Leon LG, Pacheco SC, Graves C, Yang C, McCrea AO, Frankowski JC, Garrett TJ, Febo M, Candelario-Jalil E.

Brain Behav. 2017 Apr 12;7(5):e00688. doi: 10.1002/brb3.688. eCollection 2017 May.

10.

Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats.

DeMars KM, Yang C, Hawkins KE, McCrea AO, Siwarski DM, Candelario-Jalil E.

J Exp Neurosci. 2017 Apr 7;11:1179069517701741. doi: 10.1177/1179069517701741. eCollection 2017.

11.

Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.

Hawkins KE, Moschidou D, Faccenda D, Wruck W, Martin-Trujillo A, Hau KL, Ranzoni AM, Sanchez-Freire V, Tommasini F, Eaton S, De Coppi P, Monk D, Campanella M, Thrasher AJ, Adjaye J, Guillot PV.

Mol Ther. 2017 Feb 1;25(2):427-442. doi: 10.1016/j.ymthe.2016.11.014.

12.

Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patients.

Drusbosky L, Medina C, Martuscello R, Hawkins KE, Chang M, Lamba JK, Vali S, Kumar A, Singh NK, Abbasi T, Sekeres MA, Mallo M, Sole F, Bejar R, Cogle CR.

Leuk Res. 2017 Jan;52:1-7. doi: 10.1016/j.leukres.2016.11.004. Epub 2016 Nov 6.

13.

The molecular neurobiology of the sleep-deprived, fuzzy brain.

Sweatt JD, Hawkins KE.

Sci Signal. 2016 Apr 26;9(425):fs7. doi: 10.1126/scisignal.aaf6196.

PMID:
27117249
14.

Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions.

Yang C, DeMars KM, Hawkins KE, Candelario-Jalil E.

Peptides. 2016 Jul;81:29-37. doi: 10.1016/j.peptides.2016.03.009. Epub 2016 Mar 25.

PMID:
27020249
15.

Access to chlamydia testing in remote and rural Scotland.

Hawkins KE, Thompson L, Wilson P.

Rural Remote Health. 2016 Jan-Mar;16(1):3588. Epub 2016 Mar 10.

16.

NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.

Hawkins KE, Joy S, Delhove JM, Kotiadis VN, Fernandez E, Fitzpatrick LM, Whiteford JR, King PJ, Bolanos JP, Duchen MR, Waddington SN, McKay TR.

Cell Rep. 2016 Mar 1;14(8):1883-91. doi: 10.1016/j.celrep.2016.02.003. Epub 2016 Feb 18.

17.

Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.

Frankowski JC, DeMars KM, Ahmad AS, Hawkins KE, Yang C, Leclerc JL, Doré S, Candelario-Jalil E.

Sci Rep. 2015 Dec 9;5:17956. doi: 10.1038/srep17956.

18.

Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke.

Hawkins KE, DeMars KM, Singh J, Yang C, Cho HS, Frankowski JC, Doré S, Candelario-Jalil E.

J Neurochem. 2014 Apr;129(1):130-42. doi: 10.1111/jnc.12607. Epub 2013 Dec 1.

19.

The role of hypoxia in stem cell potency and differentiation.

Hawkins KE, Sharp TV, McKay TR.

Regen Med. 2013 Nov;8(6):771-82. doi: 10.2217/rme.13.71. Review.

PMID:
24147532
20.

Supplemental Content

Loading ...
Support Center